Pathogenesis of Aβ+ Ketosis-Prone Diabetes

SG Patel, JW Hsu, F Jahoor, I Coraza, JR Bain… - Diabetes, 2013 - Am Diabetes Assoc
A− β+ ketosis-prone diabetes (KPD) is an emerging syndrome of obesity, unprovoked
ketoacidosis, reversible β-cell dysfunction, and near-normoglycemic remission. We …

Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis

AL Carlson, TD Daniel, A DeSantis… - BMJ Open Diabetes …, 2022 - drc.bmj.com
Introduction Evidence supporting use of continuous glucose monitoring in type 2 diabetes
treated with basal insulin is unclear. This real-world study aimed to assess the impact on …

Presence or absence of a known diabetic ketoacidosis precipitant defines distinct syndromes of “A-β+” ketosis-prone diabetes based on long-term β-cell function …

R Nalini, K Ozer, M Maldonado, SG Patel, CS Hampe… - Metabolism, 2010 - Elsevier
Ketosis-prone diabetes (KPD) is heterogeneous. Longitudinal follow-up revealed that
patients with “A-β+” KPD (absent autoantibodies and preserved β-cell function) segregated …

Fast acting insulin Aspart compared with insulin Aspart in the Medtronic 670G hybrid closed loop system in type 1 diabetes: an open label crossover study

K Ozer, AM Cooper, LP Ahn… - Diabetes technology …, 2021 - liebertpub.com
This is a single-center randomized open label active-controlled crossover trial comparing
efficacy and safety of fast acting insulin aspart (FA)(FIASP®) versus insulin aspart …

Islet-specific T-cell responses and proinflammatory monocytes define subtypes of autoantibody-negative ketosis-prone diabetes

BM Brooks-Worrell, D Iyer, I Coraza, CS Hampe… - Diabetes …, 2013 - Am Diabetes Assoc
OBJECTIVE Ketosis-prone diabetes (KPD) is characterized by diabetic ketoacidosis (DKA)
in patients lacking typical features of type 1 diabetes. A validated classification scheme for …

Non‐adjunctive continuous glucose monitoring for control of hypoglycaemia (COACH): results of a post‐approval observational study

SE Beck, C Kelly, DA Price… - Diabetic …, 2022 - Wiley Online Library
Abstract Objective Prior to the Continuous Monitoring and Control of Hypoglycaemia
(COACH) study described herein, no study had been powered to evaluate the impact of non …

Gene therapy with neurogenin 3 and betacellulin reverses major metabolic problems in insulin-deficient diabetic mice

V Yechoor, V Liu, A Paul, J Lee, E Buras, K Ozer… - …, 2009 - academic.oup.com
Insulin deficiency in type 1 diabetes leads to disruptions in glucose, lipid, and ketone
metabolism with resultant hyperglycemia, hyperlipidemia, and ketonemia. Exogenous …

Anatabine supplementation decreases thyroglobulin antibodies in patients with chronic lymphocytic autoimmune (Hashimoto's) thyroiditis: a randomized controlled …

LR Schmeltz, TC Blevins, SL Aronoff… - The Journal of …, 2014 - academic.oup.com
Context: Hashimoto's thyroiditis is less prevalent in tobacco smokers. Anatabine, an alkaloid
found in Solanaceae plants including tobacco, has been reported to ameliorate a mouse …

Impact of Infusion Set Materials and Designs on the Subcutaneous Response in People With Diabetes: A Rapid Review of the Literature

K Hendel, T Stumpe, K Ozer - Journal of Diabetes Science …, 2023 - journals.sagepub.com
Insulin infusion sets (IISs) are an integral and intricate part of continuous subcutaneous
insulin infusion for subjects with type 1 diabetes, infusing insulin from pump to the …

The lectin-like oxidized low-density lipoprotein receptor and its role in atherosclerosis

M Cilingiroglu, K Ozer - Current atherosclerosis reports, 2005 - Springer
The lectin-like oxidized low-density lipoprotein receptor (LOX-I), a recently identified
receptor that plays a role in the uptake of oxidized low-density lipoproteins into endothelial …